Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-09

Clinical Trial Update: Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7) [Phase 4]

View source ↗

Summary

Phase 4 relapse-prevention trial following electroconvulsive therapy compared escitalopram and nortriptyline in adults with major depressive disorder, and the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)
  • Nortriptyline (nortriptyline)

Snippet

Sponsor: Hillerod Hospital, Denmark | Conditions: Major Depression | Phase 4 | Status: TERMINATED